UFF
VRTX icon

USA Financial Formulas’s Vertex Pharmaceuticals VRTX Stock Holding History

USA Financial Formulas’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-2,115
Closed -$991K – 368
2024
Q2 		$991K Sell
2,115
-2,046
-49% -$888K 0.16% 71
2024
Q1 		$1.74M Sell
4,161
-2,279
-35% -$963K 0.28% 22
2023
Q4 		$2.62M Sell
6,440
-1,224
-16% -$452K 0.46% 16
2023
Q3 		$2.67M Sell
7,664
-2,170
-22% -$759K 3.98% 1
2023
Q2 		$3.46M Sell
9,834
-780
-7% -$263K 5.32% 1
2023
Q1 		$3.34M Buy
+10,614
New +$3.18M 5.42% 3
2022
Q3 		$3.85M Sell
13,295
-792
-6% -$228K 6.07% 1
2022
Q2 		$3.97M Buy
+14,087
New +$3.77M 4.96% 1
2022
Q1 		– Sell
-13
Closed -$3K – 495
2021
Q4 		$3K Hold
13
– – ﹤0.01% 247
2021
Q3 		$2K Hold
13
– – ﹤0.01% 331
2021
Q2 		$3K Buy
13
+3
+30% +$628 ﹤0.01% 288
2021
Q1 		$2K Buy
10
+1
+11% +$220 ﹤0.01% 280
2020
Q4 		$2K Sell
9
-9,067
-100% -$2.08M ﹤0.01% 242
2020
Q3 		$2.47M Sell
9,076
-6,289
-41% -$1.74M 1.86% 16
2020
Q2 		$4.46M Buy
15,365
+696
+5% +$189K 3.32% 8
2020
Q1 		$3.49M Buy
+14,669
New +$3.36M 2.22% 9
2019
Q1 		– Sell
-40,700
Closed -$7.84M – 353
2018
Q4 		$7.84M Buy
+40,700
New +$7.05M 1.95% 16
2017
Q4 		– Sell
-39,969
Closed -$6.08M – 344
2017
Q3 		$6.08M Buy
39,969
+17,099
+75% +$2.57M 1.45% 12
2017
Q2 		$2.95M Buy
+22,870
New +$2.75M 0.71% 58

Other funds holding VRTX

Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

USA Financial Formulas's VRTX Position: Q3 2024 in Review

USA Financial Formulas sold out of Vertex Pharmaceuticals (VRTX) in Q3 2024, closing a stake of 2,115 shares — an estimated $991K sold.

USA Financial Formulas first reported a position in VRTX in Q2 2017 and held it in 19 quarters. The position peaked at $7.84M in Q4 2018. 1,544 funds tracked by Wall St. Rank hold VRTX as of Q3 2024.

  • USA Financial Formulas reported no remaining Vertex Pharmaceuticals position as of Q3 2024 after selling out during the quarter.
  • USA Financial Formulas sold 2,115 Vertex Pharmaceuticals shares in Q3 2024, an estimated $991K.
  • USA Financial Formulas first reported a position in Vertex Pharmaceuticals in Q2 2017 and held it in 19 quarters.
  • USA Financial Formulas's Vertex Pharmaceuticals position peaked at $7.84M in Q4 2018.
  • 1,544 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q3 2024.

Based on USA Financial Formulas's 13F filing for Q3 2024, filed 8 Oct 2024.